the publicationís purpose is to be a "force for good and a platform for much needed change and to generate critical debate"..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
embolization “cuts off the blood supply to a certain part of the body,” according to the national institutes of health..
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before.